Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 6.
doi: 10.1007/s13346-025-01866-0. Online ahead of print.

Post-encapsulation methods for the preparation of mRNA-LNPs

Affiliations

Post-encapsulation methods for the preparation of mRNA-LNPs

Joanna Duffrène et al. Drug Deliv Transl Res. .

Abstract

Microfluidics mixing is the current lab-scale method used for producing mRNA-loaded lipid nanoparticles (mRNA-LNPs) thanks to reproducibility and robustness of microfluidic mixing. Despite these advantages, the production of small LNP volumes is associated with significant material waste. Given the high cost of synthetic mRNA, this waste can be a major limitation, particularly for early-stage screening of formulations. This study proposes alternative methods for mRNA-LNP formulation aiming to improve their stability for both formulation and mRNA screening, while reducing material waste on a research scale. Specifically, we investigated post-encapsulation of mRNA into pre-formed vesicles (PFVs) obtained by microfluidic mixing. These PFVs were complexed with mRNA by: (1) a microfluidic or (2) a manual pipetting method. The resulting mRNA-LNPs produced using these two post-encapsulation methods exhibit similar physicochemical properties and morphologies to those obtained by conventional microfluidic protocol. These mRNA-LNPs were assessed on in vitro and in vivo expression. mRNA-LNPs prepared by our alternative methods showed a similar transfection level compared to the conventional formulation taken as a control. The suitability of post-encapsulation methods to other lipids, mRNAs and microfluidic systems was also confirmed. This work offers robust, simple and economic alternative methods for preparing small volumes of mRNA-LNPs. The versatility of post-encapsulation methods allows to screen mRNA formulations in a wide range of laboratories. These methods could be applied to encapsulate tailored doses of mRNA and various mRNA constructs to achieve an optimal and personalized therapy.

Keywords: Lipid nanoparticles; Microfluidic; Nanomedicine; Post-encapsulation; mRNA delivery; mRNA integrity.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The cell line was cultured in the recommended conditions by the vendor and only used for research proposed described in this article. Studies were conducted following the recommendations of the European Convention for the protection of vertebrates Animals use for Experimentation and the local Ethic Committee on Animal care and Experimentation (APAFIS # 36234). Consent to publish: All the authors read and approved the final version of the manuscript. Competing interests: CM., TV., TE., S.H., and KL. are currently Neovacs employees. CM is a recipient of ANRT GRANT (French industrial research training agreement). The remaining authors declare no competing interests.

References

    1. Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25:1467–75. - DOI - PubMed - PMC
    1. Maeki M, Uno S, Niwa A, Okada Y, Tokeshi M. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. J Controlled Release. 2022;344:80–96. - DOI
    1. Kulkarni JA, Witzigmann D, Leung J, van der Meel R, Zaifman J, Darjuan MM, et al. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale. 2019;11:9023–31. - DOI - PubMed
    1. Terada T, Kulkarni JA, Huynh A, Chen S, van der Meel R, Tam YYC, et al. Characterization of lipid nanoparticles containing ionizable cationic lipids using Design-of-Experiments approach. Langmuir. 2021;37:1120–8. - DOI - PubMed
    1. Hourdel L, Lebaz N, Peral F, Ripoll M, Briançon S, Bensaid F, et al. Overview on LNP-mRNA encapsulation unit operation: mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics. Int J Pharm. 2025;672:125297. - DOI - PubMed

LinkOut - more resources